# TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

> **NCT00867568** · PHASE1 · COMPLETED · sponsor: **Giselle Sholler** · enrollment: 18 (actual)

## Conditions studied

- Neuroblastoma
- Medulloblastoma
- Relapse

## Interventions

- **DRUG:** TPI 287

## Key facts

- **NCT ID:** NCT00867568
- **Lead sponsor:** Giselle Sholler
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-09
- **Final completion:** 2016-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867568, "TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00867568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*